Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Overweight Patients with Type 1 Diabetes
NCT01753362Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Dec 2012
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by University at Buffalo. Started Dec 2012; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01753362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753362.